Optimal use of intravenous tranexamic acid for hemorrhage prevention in pregnant women.
Document Type
Journal Article
Publication Date
11-26-2020
Journal
American journal of obstetrics and gynecology
DOI
10.1016/j.ajog.2020.11.035
Keywords
pharmacodynamic; pharmacokinetic; postpartum hemorrhage; prevention; tranexamic acid
Abstract
CTSI FUNDED.
Funding text #1 The project was funded by the National Institutes of Health (NIH) (K23HL141640 and KL2TR001877/UL1TR001876 to H.K.A., R61HL141791 to A.S.W., and T32HD087969 to J.V.D.A.). Of note, this publication was supported by award numbers UL1TR001876 and KL2TR001877 from the NIH National Center for Advancing Translational Sciences .
APA Citation
Ahmadzia, H. K., Luban, N. L., Li, S., Guo, D., Miszta, A., Gobburu, J., Berger, J. S., James, A., Wolberg, A., & van den Anker, J. (2020). Optimal use of intravenous tranexamic acid for hemorrhage prevention in pregnant women.. American journal of obstetrics and gynecology, (). http://dx.doi.org/10.1016/j.ajog.2020.11.035
Peer Reviewed
1
